{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:28:46Z","timestamp":1792888126877,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Republic of Serbia Ministry of Education Science and Technological Development","doi-asserted-by":"publisher","award":["451-03-137\/2025-03\/200122"],"award-info":[{"award-number":["451-03-137\/2025-03\/200122"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Republic of Serbia Ministry of Education Science and Technological Development","doi-asserted-by":"publisher","award":["451-03-136\/2025-03\/200122"],"award-info":[{"award-number":["451-03-136\/2025-03\/200122"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejmech.2025.117972","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T16:25:01Z","timestamp":1752596701000},"page":"117972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["First bioconjugates in the role of highly effective human dihydroorotate dehydrogenase inhibitors: Synthesis, pharmacological, toxicological and hydrolytic stability studies of \u03b1-amino acid-modified pyrrolo[3,4-c]quinoline-1,3-dione scaffold"],"prefix":"10.1016","volume":"297","author":[{"given":"Marina G.","family":"Dimitrijevi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Roschger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Kehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zierer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica G.","family":"Paunovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana D.","family":"Obradovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161 M.","family":"Mati\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Klari\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nives","family":"Gali\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrija","family":"\u0106iri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljubinka","family":"Joksovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161","family":"Petkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3356-0189","authenticated-orcid":false,"given":"Milan D.","family":"Joksovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117972_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40170-021-00250-z","article-title":"DHODH and cancer: promising prospects to be explored","volume":"9","author":"Zhou","year":"2021","journal-title":"Cancer Metabol."},{"key":"10.1016\/j.ejmech.2025.117972_bib2","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.gendis.2022.04.018","article-title":"De novo nucleotide biosynthetic pathway and cancer","volume":"10","author":"Chen","year":"2023","journal-title":"Genes Dis"},{"key":"10.1016\/j.ejmech.2025.117972_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pharmthera.2018.10.012","article-title":"Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer","volume":"195","author":"Madak","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.117972_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111681","article-title":"Dihydroorotate dehydrogenase inhibitors in anti-infective drug research","volume":"183","author":"Boschi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117972_bib5","article-title":"DHODH inhibition modulates glucose metabolism and circulating GDF15, and improves metabolic balance","volume":"5","author":"Zhang","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.ejmech.2025.117972_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/1574892812666171108124218","article-title":"Use of human dihydroorotate dehydrogenase (hDHODH) inhibitors in autoimmune diseases and new perspectives in cancer therapy","volume":"13","author":"Lolli","year":"2018","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117972_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0162-3109(00)00191-0","article-title":"Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases","volume":"47","author":"Herrmann","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ejmech.2025.117972_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00415-009-0075-3","article-title":"Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the dark agouti rat model of experimental autoimmune encephalomyelitis","volume":"256","author":"Merrill","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejmech.2025.117972_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105096","article-title":"Investigating dihydroorotate dehydrogenase inhibitor mediated mitochondrial dysfunction in hepatic in vitro models","volume":"72","author":"Jones","year":"2021","journal-title":"In Vitro Toxicol."},{"key":"10.1016\/j.ejmech.2025.117972_bib10","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1021\/acs.jmedchem.7b01862","article-title":"Design, synthesis, and biological evaluation of 4-Quinoline carboxylic acids as inhibitors of dihydroorotate dehydrogenase","volume":"61","author":"Madak","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117972_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/1097-0142(19890115)63:2<243::AID-CNCR2820630207>3.0.CO;2-7","article-title":"Mucocutaneous Side Effects of Brequinar Sodium. A New Inhibitor of Pyrimidine De Novo Biosynthesis","volume":"63","author":"Schwartsmann","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ejmech.2025.117972_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23006-1","article-title":"Discovery of potential natural dihydroorotate dehydrogenase inhibitors and their synergism with brequinar via integrated molecular docking, dynamic simulations and in vitro approach","volume":"12","author":"Khairy","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117972_bib13","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3324\/haematol.2019.230482","article-title":"ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia","volume":"105","author":"Zhou","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.ejmech.2025.117972_bib14","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1182\/blood-2018-99-110570","article-title":"Preliminary results of a phase 2a dose optimization study of ASLAN003 (DHODH inhibitor) in Acute Myeloid Leukemia (AML) patients who are ineligible for standard therapy; early signs of activity","volume":"132","author":"Ting","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2025.117972_bib15","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/s41375-019-0461-5","article-title":"The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies","volume":"33","author":"Christian","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2025.117972_bib16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s40268-019-00286-z","article-title":"The selective oral immunomodulator vidofludimus in patients with active rheumatoid arthritis: safety results from the COMPONENT study","volume":"19","author":"Muehler","year":"2019","journal-title":"Drugs R&D"},{"key":"10.1016\/j.ejmech.2025.117972_bib17","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1021\/acsmedchemlett.9b00235","article-title":"The dark side of fluorine","volume":"10","author":"Pan","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117972_bib18","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.3390\/molecules27217631","article-title":"Amino-acid-conjugated natural compounds: aims, designs and results","volume":"27","author":"Arifian","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117972_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111909","article-title":"Recent advances in steroid amino acid conjugates: old scaffolds with new dimensions","volume":"187","author":"Singla","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117972_bib20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejmech.2016.03.061","article-title":"Structure\u2013activity relationship studies of new rifamycins containing l-amino acid esters as inhibitors of bacterial RNA polymerases","volume":"116","author":"Czerwonka","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117972_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202303267","article-title":"A feasible synthesis of (\u2212)-Menthol-Amino acid conjugates as potential TRPM8 agonists","volume":"8","author":"Deepalekshmi","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2025.117972_bib22","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1021\/acs.molpharmaceut.7b00263","article-title":"Bioconjugate therapeutics: current progress and future perspective","volume":"14","author":"Li","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2025.117972_bib23","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nchembio.720","article-title":"Choosing an effective protein bioconjugation strategy","volume":"7","author":"Stephanopoulos","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117972_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2022.133236","article-title":"Rapid access to pyrrolo[3,4-c]quinoline-1,3-diones: an improved synthetic protocol using a precursor prepared by Pfitzinger reaction","volume":"132","author":"Dimitrijevi\u0107","year":"2023","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117972_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107359","article-title":"Discovery of a new class of potent pyrrolo[3,4-c]quinoline-1,3-diones based inhibitors of human dihydroorotate dehydrogenase: synthesis, pharmacological and toxicological evaluation","volume":"147","author":"Dimitrijevi\u0107","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117972_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kfp097","article-title":"Chiral toxicology: it's the same thing\u2026 only different","volume":"110","author":"Smith","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejmech.2025.117972_bib27","first-page":"217","article-title":"Emerging knowledge of regulatory roles of d-amino acids in bacteria","volume":"68","author":"Cava","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2025.117972_bib28","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.7150\/jca.14835","article-title":"Dihydroorotate dehydrogenase inhibitors target c-myc and arrest melanoma, myeloma and lymphoma cells at S-phase","volume":"8","author":"Dorasamy","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.ejmech.2025.117972_bib29","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/17460441.2012.714363","article-title":"The influence of lipophilicity in drug discovery and design","volume":"7","author":"Arnott","year":"2012","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117972_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejps.2015.05.008","article-title":"Setup and validation of shake-flask procedures for the determination of partition coefficients (logD) from low drug amounts","volume":"76","author":"Andr\u00e9s","year":"2015","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2025.117972_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13321-023-00754-4","article-title":"LogD7.4 prediction enhanced by transferring knowledge from chromatographic retention time, microscopic pKa and logP","volume":"15","author":"Wang","year":"2023","journal-title":"J. Cheminf."},{"key":"10.1016\/j.ejmech.2025.117972_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115478","article-title":"Development of hydrolytic stability screening methods for early drug discovery with high differentiation and predictive power","volume":"233","author":"Wang","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejmech.2025.117972_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpba.2007.06.010","article-title":"Investigation of N-hydroxythalidomide in vitro stability and comparison to other N-substituted derivatives","volume":"45","author":"Estour","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejmech.2025.117972_bib34","series-title":"The Practice of Medicinal Chemistry","first-page":"539","article-title":"Chapter 23 - physiological aspects determining the pharmacokinetic properties of drugs","author":"Bousser","year":"2008"},{"key":"10.1016\/j.ejmech.2025.117972_bib35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/kin.21194","article-title":"On the hydrolysis mechanisms of amides and peptides","volume":"50","author":"East","year":"2018","journal-title":"Int. J. Chem. Kinet."},{"key":"10.1016\/j.ejmech.2025.117972_bib36","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/bph.15017","article-title":"Timing in drug absorption and disposition: the past, present, and future of chronopharmacokinetics","volume":"177","author":"Bicker","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117972_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/187231208785425791","article-title":"Oxidative bioactivation and toxicity of leflunomide in immortalized human hepatocytes and kinetics of the non-enzymatic to its major metabolite, A77 1726","volume":"2","author":"Quee","year":"2008","journal-title":"Drug Metabol. Lett."},{"key":"10.1016\/j.ejmech.2025.117972_bib38","article-title":"Leflunomide-induced interstitial pneumonitis: a rare occurrence in a case without underlying lung disease","volume":"33","author":"Villgran","year":"2021","journal-title":"Respir. Med. Case Rep."},{"key":"10.1016\/j.ejmech.2025.117972_bib39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0031-1296204","article-title":"Risk of hepatotoxicity with add-on leflunomide in rheumatoid arthritis patients","volume":"61","author":"Gupta","year":"2011","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejmech.2025.117972_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107398","article-title":"Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: a comprehensive review","volume":"93","author":"Alamri","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.117972_bib41","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","article-title":"Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging","volume":"97","author":"Jomova","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117972_bib42","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.intimp.2004.11.013","article-title":"Leflunomide reduces nitric oxide production in patients with active rheumatoid arthritis","volume":"6","author":"Reddy","year":"2005","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.117972_bib43","article-title":"Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis","volume":"13","author":"Su","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2025.117972_bib44","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jss.2013.11.005","article-title":"Protective effect of leflunomide against oxidative intestinal injury in a rodent model of sepsis","volume":"187","author":"Ozturk","year":"2014","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ejmech.2025.117972_bib45","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.bbrc.2018.07.149","article-title":"Leflunomide attenuates oxidative stress in fetal human lung endothelial cells via superoxide dismutase 2 and catalase","volume":"503","author":"Shrestha","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2025.117972_bib46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/toxics10050274","article-title":"The anti-rheumatic drug, leflunomide, induces nephrotoxicity in mice via upregulation of TGF\u03b2-Mediated p53\/Smad2\/3 signaling","volume":"23","author":"Aljohani","year":"2022","journal-title":"Toxics"},{"key":"10.1016\/j.ejmech.2025.117972_bib47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fphar.2014.00073","article-title":"Glutathione synthesis is compromised in erythrocytes from individuals with HIV","volume":"5","author":"Morris","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117972_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13145","article-title":"Understanding oxidants and antioxidants: classical team with new players","volume":"44","author":"Ali","year":"2020","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.ejmech.2025.117972_bib49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00383-009-2529-1","article-title":"Effect of leflunomide on liver regeneration after partial hepatectomy in rats","volume":"26","author":"Karaman","year":"2010","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.ejmech.2025.117972_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0969-2126(00)00077-0","article-title":"Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents","volume":"8","author":"Liu","year":"2000","journal-title":"Struct"},{"key":"10.1016\/j.ejmech.2025.117972_bib51","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1021\/jm800963t","article-title":"Structure-based design, synthesis, and characterization of inhibitors of human and plasmodium falciparum dihydroorotate dehydrogenases","volume":"52","author":"Davies","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117972_bib52","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1021\/acs.jafc.6b05103","article-title":"Effect of in vitro gastrointestinal digestion on encapsulated and nonencapsulated phenolic compounds of carob (Ceratonia siliqua L.) pulp extracts and their antioxidant capacity","volume":"65","author":"Ydjedd","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2025.117972_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cbi.2017.04.009","article-title":"Methotrexate hepatotoxicity is associated with oxidative stress, and down-regulation of PPAR\u03b3 and Nrf2: protective effect of 18\u03b2-Glycyrrhetinic acid","volume":"270","author":"Mahmoud","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2025.117972_bib54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41401-019-0283-z","article-title":"Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1\/3 and MRP2","volume":"41","author":"Liao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.117972_bib55","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/01480545.2019.1587451","article-title":"Hematoprotective effects and antioxidant properties of \u03b2-glucan and vitamin C against acetaminophen-induced toxicity: an experimental study in rats","volume":"44","author":"Mati\u0107","year":"2019","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117972_bib56","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1471-4159.1980.tb11254.x","article-title":"Peroxidative changes in brain cortical fatty acids and phospholipids, as characterized during Fe2+\u2010and ascorbic acid\u2010stimulated lipid peroxidation in vitro","volume":"34","author":"Rehncrona","year":"1980","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2025.117972_bib57","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2025.117972_bib58","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0003-2697(90)90208-Q","article-title":"Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples","volume":"190","author":"Baker","year":"1990","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2025.117972_bib59","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase","volume":"47","author":"Marklund","year":"1974","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2025.117972_bib60","series-title":"Red Cell Metabolism, a Manual of Biochemical Methods","first-page":"105","article-title":"Catalase","author":"Beutler","year":"1982"},{"key":"10.1016\/j.ejmech.2025.117972_bib61","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117972_bib62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-9258(18)74965-X","article-title":"Spectrophotometric studies: II. Preparations from washed blood cells; nitric oxide hemoglobin and sulfhemoglobin","volume":"112","author":"Drabkin","year":"1935","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117972_bib63","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-functional thermochemistry. III. The role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.117972_bib64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF01114537","article-title":"Energy-adjusted ab initio pseudopotentials for the second and third row transition elements","volume":"77","author":"Andrae","year":"1990","journal-title":"Theor. Chim. Acta"},{"key":"10.1016\/j.ejmech.2025.117972_bib65","series-title":"Gaussian 09, Revision C.01","author":"Frisch","year":"2010"},{"key":"10.1016\/j.ejmech.2025.117972_bib66","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm051197e","article-title":"MolDock: a new technique for high-accuracy molecular docking","volume":"49","author":"Thomsen","year":"2006","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425007378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425007378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:52:08Z","timestamp":1776919928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425007378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":66,"alternative-id":["S0223523425007378"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117972","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First bioconjugates in the role of highly effective human dihydroorotate dehydrogenase inhibitors: Synthesis, pharmacological, toxicological and hydrolytic stability studies of \u03b1-amino acid-modified pyrrolo[3,4-c]quinoline-1,3-dione scaffold","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117972"}}